Not Medicare Enrolled
Dr. Richard Knipe, MD
Hematology · St Petersburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Knipe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Knipe? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Knipe
Dr. Richard Knipe is a hematology in St Petersburg, FL, with 20 years in practice. Based on federal Medicare data, Dr. Knipe performed 231,898 Medicare services across 3,903 unique beneficiaries.
Between the years covered by Open Payments, Dr. Knipe received a total of $18,031 from 90 pharmaceutical and/or device companies across 680 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Knipe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 17% volume in FL$ $18,031 industry payments
Medicare Practice Summary
Medicare Utilization ↗231,898
Medicare services
Top 17% in FL for hematology
3,903
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11,595 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells | 51,120 | $0 | $2 |
| Iron infusion (Feraheme) | 36,210 | $0 | $4 |
| Filgrastim injection (Nivestym) for white blood cells | 35,760 | $0 | $1 |
| Iron sucrose injection (Venofer) | 23,500 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 18,800 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 14,040 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 10,710 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 9,600 | $18 | $51 |
| Immune globulin infusion (Gammagard) | 4,800 | $36 | $108 |
| Dexamethasone injection (steroid) | 4,500 | $0 | $3 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,960 | $26 | $116 |
| Injection, fulvestrant, 25 mg | 2,580 | $8 | $132 |
| Complete blood count (CBC) with differential | 2,531 | $8 | $29 |
| Blood draw (venipuncture) | 2,392 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,620 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,248 | $96 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 1,248 | $0 | $9 |
| Drug injection, under skin or into muscle | 1,138 | $10 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 650 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 558 | $22 | $84 |
| Cyclophosphamide, 100 mg | 524 | $15 | $79 |
| Office visit, established patient (20-29 min) | 513 | $62 | $239 |
| Injection, fluorouracil, 500 mg | 387 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 384 | $47 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 338 | $1 | $6 |
| Injection of additional new drug or substance into vein | 321 | $12 | $61 |
| Injection, carboplatin, 50 mg | 275 | $2 | $41 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 261 | $25 | $89 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 208 | $15 | $56 |
| Injection, diphenhydramine hcl, up to 50 mg | 198 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 178 | $21 | $79 |
| Infusion into a vein for hydration, each additional hour | 164 | $10 | $42 |
| Administration of additional new drug or substance into vein using push technique | 139 | $41 | $170 |
| Administration of additional new drug or substance into vein, 1 hour or less | 121 | $49 | $178 |
| Infusion, normal saline solution , 1000 cc | 118 | $2 | $7 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 97 | $3 | $11 |
| Injection, zoledronic acid, 1 mg | 88 | $7 | $69 |
| Infusion into a vein for hydration, 31-60 minutes | 79 | $25 | $156 |
| Office visit, established patient, complex (40-54 min) | 76 | $134 | $474 |
| Injection, magnesium sulfate, per 500 mg | 76 | $1 | $2 |
| New patient office visit (45-59 min) | 75 | $113 | $453 |
| Red blood count, automated test | 64 | $4 | $10 |
| Automated urinalysis | 43 | $2 | $8 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 41 | $17 | $59 |
| Initial hospital admission, high complexity | 41 | $133 | $556 |
| Injection of drug or substance into vein | 40 | $28 | $156 |
| New patient office visit, complex (60-74 min) | 39 | $153 | $585 |
| Hospital follow-up visit, high complexity | 25 | $90 | $285 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 20 | $1 | $7 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.3% high complexity
78.3% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,031
Total received (2018-2024)
Avg $2,576/year across 7 years
Top 27% in FL for hematology
90
Companies
680
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,011 (66.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,208 (17.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,813 (15.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,363
2023$5,340
2022$4,361
2021$508
2020$1,033
2019$2,015
2018$2,410
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,061
Novartis Pharmaceuticals Corporation
$1,356
AstraZeneca Pharmaceuticals LP
$989
E.R. Squibb & Sons, L.L.C.
$941
AVEO Pharmaceuticals, Inc.
$933
PFIZER INC.
$832
Genentech USA, Inc.
$586
Daiichi Sankyo Inc.
$526
Lilly USA, LLC
$519
Amgen Inc.
$444
GENZYME CORPORATION
$432
Gilead Sciences, Inc.
$414
BeiGene USA, Inc.
$388
Alexion Pharmaceuticals, Inc.
$336
GlaxoSmithKline, LLC.
$334
Athenex Pharmaceutical Division, LLC
$325
Blueprint Medicines Corporation
$307
Seagen Inc.
$305
Incyte Corporation
$279
Astellas Pharma US Inc
$265
Celgene Corporation
$265
SOBI, INC
$261
COMSORT, Inc
$250
Takeda Pharmaceuticals U.S.A., Inc.
$247
Merck Sharp & Dohme LLC
$234
ABBVIE INC.
$230
Merck Sharp & Dohme Corporation
$211
Novocure GmbH
$200
JAZZ PHARMACEUTICALS INC.
$185
EMD Serono, Inc.
$170
CTI BioPharma Corp.
$166
Regeneron Healthcare Solutions, Inc.
$164
Novocure Inc.
$142
Exelixis Inc.
$140
TerSera Therapeutics LLC
$131
Kite Pharma, Inc.
$115
NanoString Technologies, Inc.
$107
Eisai Inc.
$100
Cardinal Health 110 LLC
$100
Pharmacyclics LLC, An AbbVie Company
$98
Stemline Therapeutics Inc.
$96
AbbVie, Inc.
$91
Rigel Pharmaceuticals, Inc.
$88
Sumitomo Pharma America, Inc.
$83
TAIHO ONCOLOGY, INC.
$74
Pharmacyclics LLC, an AbbVie Company
$74
EISAI INC.
$72
Puma Biotechnology, Inc.
$67
SpringWorks Therapeutics, Inc.
$61
Sobi, Inc
$57
Karyopharm Therapeutics Inc.
$56
Array BioPharma Inc.
$56
Myovant Sciences Inc.
$56
Bayer Healthcare Pharmaceuticals Inc.
$55
Bayer HealthCare Pharmaceuticals Inc.
$53
Taiho Oncology, Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
CSL Behring
$50
Mirati Therapeutics, Inc.
$43
PUMA BIOTECHNOLOGY, INC.
$41
Janssen Pharmaceuticals, Inc
$39
Smith+Nephew, Inc.
$39
Sysmex Inostics Inc
$38
Lexicon Pharmaceuticals, Inc.
$37
Novo Nordisk Inc
$37
Ipsen Biopharmaceuticals, Inc
$36
Myriad Genetic Laboratories, Inc.
$32
Sun Pharmaceutical Industries Inc.
$26
Dova Pharmaceuticals
$26
Seattle Genetics, Inc.
$26
Deciphera Pharmaceuticals Inc.
$24
Fennec Pharmaceuticals, Inc.
$23
MorphoSys, US Inc.
$20
Acrotech Biopharma Inc.
$20
Aurobindo Pharma USA, Inc.
$20
R-Pharm US LLC
$20
Pharmacosmos Therapeutics Inc.
$19
Allergan Inc.
$19
MEDIVATION FIELD SOLUTIONS LLC
$18
Aveo Pharmaceuticals, Inc.
$18
Global Blood Therapeutics, Inc.
$18
GE HealthCare
$17
EUSA Pharma (US) LLC
$15
Alnylam Pharmaceuticals Inc.
$14
Shire North American Group Inc
$14
ARRAY BIOPHARMA INC
$12
Helsinn Therapeutics (U.S.), Inc.
$12
Sysmex America, Inc.
$12
NOVARTIS PHARMACEUTICALS CORPORATION
$11
Veracyte, Inc.
$1
Top 3 companies account for 24.4% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Avastin · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Creon · Cresemba · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Enhertu · FASLODEX · FOTIVDA · FRUZAQLA · Fabhalta · GAMMAGARD · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INLYTA · Idelvion · Ixempra · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ODOMZO · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Oral Paclitaxel · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · PROMACTA · PROSIGNA ASSAY · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rebinyn · Revlimid · Rezlidhia · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Santyl · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XN Series · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · ZYKADIA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (67%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
42
Per 100K population
4.4
County median income
$70,293
Nearest hospital
ORLANDO HEALTH BAYFRONT HOSPITAL
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Knipe is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Knipe experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Knipe performed 51,120 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Knipe receive payments from pharmaceutical companies?
Yes. Dr. Knipe received a total of $18,031 from 90 companies across 680 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Knipe's costs compare to other hematologys in St Petersburg?
Dr. Knipe's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Knipe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in St Petersburg
Browse hematologys in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology